May 24, 2023

Public workspaceMito-Keima assay to assess mitophagy

  • Thanh Ngoc Nguyen1
  • 1Laboratory of Michael Lazarou, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Thanh Ngoc Nguyen: nguyen.tha@wehi.edu.au
Icon indicating open access to content
QR code linking to this content
Protocol CitationThanh Ngoc Nguyen 2023. Mito-Keima assay to assess mitophagy. protocols.io https://dx.doi.org/10.17504/protocols.io.q26g74e1qgwz/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: July 19, 2022
Last Modified: May 31, 2024
Protocol Integer ID: 67007
Keywords: Mito-Keima, Mitophagy, BFP-Parkin, ASAPCRN
Funders Acknowledgement:
Aligning Science Across Parkinson’s
Grant ID: ASAP-000350
Abstract
This protocol details the procedure of mito-keima assay to assess mitophagy.
Attachments
Materials
Growth media:

DMEM:
AB
FBS10%
Glucose4.5 g/l
GlutaMAXTM1x
MEM NEAA1x
HEPES25 mM
  • Reagent45% D-( )-GlucoseSigmaCatalog #G8769
  • ReagentGlutaMAX™ SupplementThermo Fisher ScientificCatalog #35050061
  • ReagentMEAA (MEM Non-Essential Amino Acids)Gibco - Thermo FischerCatalog #11140050
  • ReagentAntimycin A from Streptomyces sp.Sigma – AldrichCatalog #A8674 (made up in 100% Ethanol to 20 mg/ml)
  • Oligomycin (Calbiochem, 495455; made up in DMSO to 10 mg/ml) and
  • ReagentqVDMedChemExpressCatalog #HY-12305 (made up in DMSO to 10 mM)
  • 1x PBS
  • FACS buffer: 10% FBS, Concentration0.5 millimolar (mM) EDTA in 1xPBS

Procedure
Procedure
2h 9m
2h 9m
Seed the HeLa cells the day before the treatment day in 24 well plates.
Note
Each well contained 0.5 ml of growth media; 120,000 cells were seeded for penta KO expressing BFP-Parkin, mito-Keima (mtKeima) and GFP-OPTN or -NDP52; the number of cells of other cell lines were adjusted so that the next day they are all in similar confluency with penta KO expressing BFP-Parkin, mtKeima and GFP-OPTN or -NDP52.

Control cells include unstained cells (without any fluorescence proteins), cells that only express GFP-OPTN or GFP-NDP52 (to set up compensation so that GFP signal doesn’t bleach into mtKeima signal.
The next day, make sure the seeded cells are spreading out.
Note
Not concentrated in the middle of the well because this can affect the results.

Aspirate off the old media and treat each well with Amount0.5 mL of growth media containing Concentration4 micromolar (µM) Antimycin A, Concentration10 micromolar (µM) Oligomycin and Concentration10 micromolar (µM) QVD for indicated times.
Note
Make sure all drugs are vortexed well, mix the media well after adding each drug.

Pipetting
Mix
Treat the longest time points first.
2 hours prior to harvesting, feed the untreated wells with Amount1 mL of warm growth media.
Pipetting
Aftrer treatment, harvest the cells by trypsinisation.
Pre-chill eppies TemperatureOn ice .

Aspirate the media thoroughly from the wells.
Wash the wells with Amount0.5 mL of 1x PBS.
Note
Make sure swirl around after adding the PBS to wash the cells properly.

Wash
Aspirate 1x PBS and add Amount150 µL of trypsin and incubate at Temperature37 °C for Duration00:02:00 -Duration00:05:00 .
Note
Check under microscope to make sure all the cells were trypsinised properly.

7m
Incubation
Pipetting
Imaging
Add Amount300 µL of growth media to each well.
Pipetting
Mix well with a P1000 and transfer the cells to cold eppies.
Mix
Centrifuge the eppies at Centrifigation1000 x g for Duration00:02:00 at Temperature4 °C .
2m
Centrifigation
Aspirate off the liquid.
Resuspend the cell pellets in Amount150 µL of FACS buffer, transfer to pre-chilled FACS tubes and keep the samples TemperatureOn ice in the dark for analysis.